HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Systematic review of topical treatments for fungal infections of the skin and nails of the feet.

AbstractOBJECTIVE:
To identify and synthesise the evidence for efficacy and cost effectiveness of topical treatments for superficial fungal infections of the skin and nails of the feet.
DESIGN:
Systematic review.
INTERVENTIONS:
Topical treatments for superficial fungal infections.
MAIN OUTCOME MEASURES:
Cure confirmed by culture and microscopy for skin and by culture for nails in patients with clinically diagnosed fungal infections.
RESULTS:
Of 126 trials identified in 121 papers, 72 (57.1%) met the inclusion criteria. Placebo controlled trials yielded pooled relative risks of failure to cure skin infections: allylamines (0.30, 95% confidence interval 0.24 to 0.38); azoles (0.54, 0.42 to 0.68); undecenoic acid (0.28, 0. 11 to 0.74); and tolnaftate (0.46, 0.17 to 1.22). Although meta-analysis of 11 trials comparing allylamines and azoles showed a relative risk of failure to cure of 0.88 (0.78 to 0.99) in favour of allylamines, there was evidence of language bias. Seven reports in English favoured allylamines (0.79, 0.69 to 0.91), but four reports in foreign languages showed no difference between the two drugs (1. 01, 0.90 to 1.13). Neither trial of nail infections showed significant differences between alternative topical treatments.
CONCLUSIONS:
Allylamines, azoles, and undecenoic acid were efficacious in placebo controlled trials. There are sufficient comparative trials to judge relative efficacy only between allylamines and azoles. Allylamines cure slightly more infections than azoles but are much more expensive than azoles. The most cost effective strategy is first to treat with azoles or undecenoic acid and to use allylamines only if that fails.
AuthorsR Hart, S E Bell-Syer, F Crawford, D J Torgerson, P Young, I Russell
JournalBMJ (Clinical research ed.) (BMJ) Vol. 319 Issue 7202 Pg. 79-82 (Jul 10 1999) ISSN: 0959-8138 [Print] England
PMID10398626 (Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review)
Chemical References
  • Antifungal Agents
  • Azoles
  • Nonprescription Drugs
  • Allylamine
Topics
  • Administration, Topical
  • Allylamine (administration & dosage, economics, therapeutic use)
  • Antifungal Agents (administration & dosage, economics, therapeutic use)
  • Azoles (administration & dosage, economics, therapeutic use)
  • Cost-Benefit Analysis
  • Dermatomycoses (drug therapy)
  • Foot Dermatoses (drug therapy)
  • Humans
  • Nonprescription Drugs (administration & dosage, economics, therapeutic use)
  • Onychomycosis (drug therapy)
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: